KAREN THRIFT: Open Payments
NPI 1093031619 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,999 in 73 payments from 24 companies in 2025. Trend: 2023 $896 · 2024 $3,209 · 2025 $1,999
Food & beverage: $1,999
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 5 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $213 |
| Amgen Inc. | 7 | $201 |
| Novo Nordisk Inc | 5 | $194 |
| Medtronic, Inc. | 5 | $184 |
| AstraZeneca Pharmaceuticals LP | 8 | $147 |
| Lilly USA, LLC | 8 | $116 |
| Madrigal Pharmaceuticals | 1 | $103 |
| ABBVIE INC. | 4 | $82 |
| Tandem Diabetes Care, Inc. | 4 | $81 |
Products named: TZIELD, JARDIANCE, EVENITY, MINIMED 780G, Ozempic, MOUNJARO, REZDIFFRA, UBRELVY.
Industry payments across AR — which companies pay providers there.
